Boothbay Fund Management, LLC Aurinia Pharmaceuticals Inc. Call Options Transaction History

Boothbay Fund Management, LLC

  • $3.6 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$8.96 - $11.69 $30,464 - $39,746
-3,400 Reduced 20.73%
13,000 $125,000
Q1 2023

May 15, 2023
BUY
$5.94 - $11.27 $97,416 - $184,828
16,400 New
16,400 $179,000
Q4 2021

Feb 14, 2022
SELL
$17.78 - $33.08 $353,822 - $658,292
-19,900 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$10.93 - $23.55 $217,507 - $468,645
19,900 New
19,900 $440,000

Others Institutions Holding AUPH

# of Institutions
208
Shares Held
58.1M
Call Options Held
1.14M
Put Options Held
1.51M
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.14B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email